Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 14;13(6):1671.
doi: 10.3390/jcm13061671.

Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction

Affiliations

Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction

Cesare de Gregorio et al. J Clin Med. .

Abstract

Background: The pathophysiological impact of systemic vascular resistance (SVR) and pressure-strain loop-derived global myocardial work index (GWI) in hypertrophic cardiomyopathy (HCM) and transthyretin cardiac amyloidosis (ATTR) has been randomly investigated. Methods: Both SVR and GWI were assessed in outpatients consecutively referred at two Italian cardiology departments for heart failure with preserved left ventricular ejection fraction (LVEF), affected by either nonobstructive HCM or wild-type ATTR. Based on relevant cross-tabulations, the patients were gathered into 4 functional classes according to cut-off values of 1440 dyne/s/cm-5 for SVR, and 1576 mm Hg% for GWI, as suggested by previous studies. Results: A total of 60 patients, 30 in each group, aged 61 ± 16 years, with 78% males, were studied. HCM patients were younger than those with ATTR and in a better clinical condition (23% HCM vs. 77% ATTR were NYHA class II-III, p < 0.001). Overall, 51 patients (85%) showed a high SVR, 21/30 HCM (70%), and 30 ATTR (100%) (p < 0.005). Both SVR and GWI (expressions of ventricular-arterial coupling) were impaired in 43% of HCM patients (showing greater LV concentric hypertrophy) and 93% of ATTR patients (in advanced NYHA functional class) (p < 0.001). Conclusions: A substantial percentage of present study population showed impaired SVR and/or GWI, despite preserved LVEF. The proposed classification may shed further light on the pathophysiological and clinical characteristics of such hypertrophic phenotypes.

Keywords: cardiac amyloidosis; heart failure with preserved left ventricular ejection fraction; hypertrophic cardiomyopathy; strain echocardiography; systemic vascular resistance; ventricular arterial coupling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 2
Figure 2
Scatter plot diagram showing four classes categorized according to SVRc (cut-off 1440 dyne/cm/s−5) [3,8] and GWI (cut-off 1576 mm Hg%) [18]. Therefore, Class A included patients with low/normal SVRc and preserved GWI, then interpreted as the best functional class. Class B included patients with lower GWI and normal SVRc, taken as intermediate risk class. Class C included patients with higher SVRc and impaired GWI, then considered as the worst one. Class D, another intermediate class due to high SVRc. Vertical dashed lines indicate the cut-off values by previous studies for impaired myocardial perfusion and late gadolinium enhancement (LGE) in HCM patients [21], and major cardiovascular events (MACE) in ATTR patients [22]. Tabulation below the graphics refers to some clinical findings from the patients belonging to different Classes (see also Table 3). ATTRwt, wild-type transthyretin cardiac amyloidosis; HCM, nonobstructive hypertrophic cardiomyopathy; NYHA, New York Heart Association functional class; NSVT, nonsustained ventricular tachycardia on 24-h ECG Holter monitoring; PAF, paroxysmal atrial fibrillation.
Figure 1
Figure 1
Median values of global myocardial constructive work (GCW), global work index (GWI) and systemic vascular resistance (SVRc) in the study population. ATTR, wild-type transthyretin amyloid cardiomyopathy HCM, hypertrophic cardiomyopathy; SVRc, systemic vascular resistance, corrected (see methods). HCM vs. ATTR: * p = 0.008; # p = 0.001. Differences in SVRc between the groups were significant (p = 0.008).

References

    1. Wiggers C.J. Determinants of Cardiac Performance. Circulation. 1951;4:485–495. doi: 10.1161/01.CIR.4.4.485. - DOI - PubMed
    1. Ilebekk A. Determinants of Cardiac Performance. J. Oslo City Hosp. 1979;29:91–102. - PubMed
    1. Stefadouros M.A., Dougherty M.J., Grossman W., Craige E. Determination of Systemic Vascular Resistance by a Noninvasive Technic. Circulation. 1973;47:101–107. doi: 10.1161/01.CIR.47.1.101. - DOI - PubMed
    1. Schiffrin E.L. Remodeling of Resistance Arteries in Essential Hypertension and Effects of Antihypertensive Treatment. Am. J. Hypertens. 2004;17:1192–1200. doi: 10.1016/j.amjhyper.2004.05.023. - DOI - PubMed
    1. Trammel J.E., Sapra A. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2023. Physiology, Systemic Vascular Resistance. - PubMed